Rice Hall James & Associates’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Buy
91,887
+6,900
+8% +$27.4K 0.02% 232
2025
Q4
$298K Buy
84,987
+1,980
+2% +$6.78K 0.02% 233
2025
Q3
$271K Sell
83,007
-9,391
-10% -$29.6K 0.01% 242
2025
Q2
$226K Buy
92,398
+4,879
+6% +$24.7K 0.01% 245
2025
Q1
$584K Sell
87,519
-3,315
-4% -$32.8K 0.03% 213
2024
Q4
$1.14M Sell
90,834
-1,308
-1% -$19.7K 0.06% 199
2024
Q3
$1.7M Buy
92,142
+16,719
+22% +$342K 0.09% 188
2024
Q2
$1.62M Buy
75,423
+2,895
+4% +$66.5K 0.1% 178
2024
Q1
$1.95M Buy
72,528
+100
+0.1% +$2.84K 0.11% 173
2023
Q4
$2.17M Sell
72,428
-4,961
-6% -$109K 0.13% 166
2023
Q3
$1.59M Sell
77,389
-1,597
-2% -$29K 0.1% 188
2023
Q2
$1.57M Buy
78,986
+3,311
+4% +$66.9K 0.09% 191
2023
Q1
$1.3M Buy
+75,675
New +$1.48M 0.07% 225

Other funds holding RCKT